Status:
COMPLETED
Epidemiology of Schizophrenia in Bulgaria
Lead Sponsor:
AstraZeneca
Conditions:
Schizophrenia
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to provide accurate, reliable information on schizophrenia clinical management in order to detect unmet medical needs of this disease in terms of: * Patient characteristi...
Eligibility Criteria
Inclusion
- Patients with schizophrenia
- Above 18 years
- Signed Informed consent
Exclusion
- Below 18 years
- Consent refused
Key Trial Info
Start Date :
September 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
440 Patients enrolled
Trial Details
Trial ID
NCT00984373
Start Date
September 1 2009
End Date
November 1 2009
Last Update
February 4 2010
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Burgas, Bulgaria
2
Research Site
Pazardzhik, Bulgaria
3
Research Site
Sofia, Bulgaria
4
Research Site
Stara Zagora, Bulgaria